BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Net Tangible Assets

Latest net tangible assets for MLTX: $250M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$254.02M

Peer average

Loading

MoonLake Immunotherapeutics Net Tangible Assets History

Loading

MoonLake Immunotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

MoonLake Immunotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MoonLake Immunotherapeutics (MLTX) FAQ

MoonLake Immunotherapeutics's net tangible assets stands at $250M as of March 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

MoonLake Immunotherapeutics reported $250M in net tangible assets versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in net tangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how MoonLake Immunotherapeutics's net tangible assets evolved across reporting periods, while the comparison chart places MLTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.